Favipiravir for the treatment of COVID-19 in elderly patients—what do we know after 2 years of COVID-19?

Since the appearance of coronavirus disease 2019 (COVID-19), numerous studies have been conducted to find effective therapeutics. Favipiravir (FVP) is one of the repurposed drugs which has been authorized in a few countries on an emergency basis to treat COVID-19. Elderly individuals especially 65 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, Henrietta, Lanszki, Zsófia, Keserű, György M., Jakab, Ferenc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091543/
https://www.ncbi.nlm.nih.gov/pubmed/35543795
http://dx.doi.org/10.1007/s11357-022-00582-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091543/
https://www.ncbi.nlm.nih.gov/pubmed/35543795
http://dx.doi.org/10.1007/s11357-022-00582-8

Ejemplares similares